← Leaderboards
Fazli Kamer Bozal
New York University School Of Medicine
$161,206
Attributed
$161,206
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $54.5K · FY2023–25$100K$75K$50K$25K$0
'23
'24
'25
Funding mix
By agency
NIH$161,206 · 1
By mechanism
F30$161,206 · 1
Top collaborators
No co-investigators on record.
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Ira Jay Goldberg$42,989,404
- M Mahmood Hussain$20,347,941
- Allison B Reiss$1,032,144
- Shane Liddelow$2,504,198
- Jose Orlando Aleman$1,497,764
Others in their field
Other Rising Stars on “Chronic”
- Rebecca Montalvan · Westat, Inc.$86,600,000
- Taleen Hanania · Psychogenics, Inc.$9,482,040
- James Cappo · National Jewish Health$9,298,220
- Christine W Hockett · Avera Mckennan$8,908,366
- Iii, Josiah J. Sampson · Tougaloo College$8,000,000
- Rosianna R Gray · Stillman College$7,999,408
Research focus
ChronicChromatinCholesterolCessation Of LifeAcuteAnti-Inflammatory AgentsAconitic AcidActivating Transcription Factor 3AortaAgonistArterial Fatty StreakAntibodiesArteriesAtf2 GeneAcute DiseaseAtherosclerosisCardiovascular DiseasesCardiovascular SystemCause Of DeathCell PhysiologyCellsAreaCellular Metabolic ProcessChronic Inflammatory Disease
Grant awards (3)
The role of Immune-responsive gene 1 and itaconate in atherosclerotic disease$54,538
F30 · FY2025 · HL · contact PI
The role of Immune-responsive gene 1 and itaconate in atherosclerotic disease$53,974
F30 · FY2024 · HL · contact PI
The role of Immune-responsive gene 1 and itaconate in atherosclerotic disease$52,694
F30 · FY2023 · HL · contact PI